EMR

The global oligonucleotide synthesis market will be driven by favorable government initiatives for funding and increasing R&D activities in pharmaceutical and biotech companies in the forecast period of 2022-2027

Expert Market Research’s new report titled “Global Oligonucleotide Synthesis Market Report and Forecast 2022-2027”, provides an in-depth analysis of the global Oligonucleotide Synthesis market, evaluating the market based on its segments such as product, application, end use, and the main regions. The report tracks the latest industry trends and studies their impact on the global market. It also assesses market dynamics, covering key demand and price indicators, as well as analyzing the market based on Porter’s SWOT and Five Forces models.

Request a free sample copy in PDF or view the report summary at https://www.expertmarketresearch.com/reports/oligonucleotide-synthesize-market/requestsample

Highlights of the report include:

Market overview (2017-2027)

  • CAGR forecast (2022-2027): 13.1%

North America was an important geographic market for oligonucleotide synthesis in the past and is expected to remain so in the future. The market for oligonucleotide synthesis has been catalyzed by the growing importance of research and development in the life sciences, which can be attributed to this region’s increased focus on improving the safety and quality of health care, the growing demand for tools of high-quality research for data reproducibility, and the growing focus on the development of personalized therapies.

In the years to come, the Asia Pacific oligonucleotide synthesis industry is expected to grow at a healthy pace. Some of the key factors supporting the expansion of oligonucleotide synthesis activity in the Asia Pacific area include the growing availability of synthesized oligonucleotides, the strong presence of pharmaceutical and biotech companies, and the growing outsourcing of research to CROs. Improved health infrastructure, increased use of oligonucleotides by regional pharmaceutical companies, and numerous strategic alliances between key market players are expected to advance the oligonucleotide synthesis industry in the region.

Definition of the sector and main segments

Single-stranded DNA fragments that have been chemically synthesized into short segments are known as synthetic oligonucleotides. The approach is particularly beneficial in the laboratory as it allows researchers to obtain customized oligonucleotides of the appropriate sequence quickly and at low cost. It can also be used for molecular diagnosis in a variety of disorders, including the identification of infectious diseases such as hepatitis and SARS-COV2, as well as for the diagnosis of cancer.

Explore full report with table of contents @ https://www.expertmarketresearch.com/reports/oligonucleotide-synthesize-market

By product, the market can be segmented into:

  • Oligonucleotides
    • Break by type:
      • Columned oligos
      • Array-based oligos
    • Rupture by type of nucleic acid
  • Equipment / synthesizer
  • Reagents
  • Services
    • By type:
    • According to the quantity:
      • 25 nmol
      • 50 nmol
      • 200 nmol
      • 1,000 nmol
      • 10,000 nmol
  • Purification
  • Edit

Based on the application, the oligonucleotide synthesis industry is segmented into:

  • PCR primer
  • PCR analysis panels
  • Sequence
  • DNA microarrays
  • Fluorescent in situ hybridization (FISH)
  • Antisense oligonucleotides
  • Other

Based on the end use, the market is classified into:

Latest News on Global Oligonucleotide Synthesis Market @ https://www.expertmarketresearch.com/pressrelease/global-oligonucleotide-sintesi-market

Regional markets for oligonucleotide synthesis can be divided into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • the Middle East and Africa

Market trend

One of the factors driving market growth is an increase in R&D spending by pharmaceutical and biotech companies to develop oligonucleotide products with greater therapeutic potential and fewer adverse effects. The market is likely to grow even faster as government funding for synthetic biology and genome projects grows, as well as through rigorous research. Government investments have significantly fostered the development of new technologies. More investment and development in these sectors is expected to fuel the growth of the oligonucleotide synthesis market. These ongoing, government-funded studies are expected to advance genomic technologies such as DNA sequencing, DNA amplification, next generation sequencing (NGS) and gene expression.

The growing demand for high-end bespoke oligonucleotides and improvements in purification of synthetic oligonucleotides are also helping the growth of the oligonucleotide synthesis industry. In recent years, major players have acquired several small-scale oligonucleotide synthesis companies to broaden their product and service offerings and expand their footprint in the oligonucleotide synthesis industry, which has helped market growth. Advances in enzyme failure repair technology have also reduced the occurrence of synthesis failures, which are expected to increase market expansion in the coming years.

Main market players

Major competitors identified in this market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Merck KGaA, Agilent Technologies, Inc., Bio-Synthesis Inc., and LGC Biosearch Technologies. The report covers market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments from these market players.

Who we are:

Expert Market Research is a leading business intelligence firm, providing customized and syndicated market reports along with consulting services for our clients. We serve a broad customer base ranging from Fortune 1000 companies to small and medium-sized businesses. Our reports cover over 100 sectors in established and emerging markets researched by our expert analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach to the needs and preferences of our clients, providing them with valuable, actionable and up-to-date market information, thereby helping them realize their optimal growth potential. We offer market information across a broad range of verticals including pharmaceuticals, food and beverage, technology, retail, chemicals and materials, energy and mining, packaging and agriculture.

Contact with the media

Business Name: EMR Inc.
Contact Person: Steven Luke, Corporate Sales Specialist – USA
Email: sales@expertmarketresearch.com
Toll-free number: + 1-415-325-5166 | + 44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States
Website: https://www.expertmarketresearch.com

Plus, Check Procurement Intelligence which provides you with foolproof research solutions.

* We at Expert Market Research always try to provide you with the latest information. The numbers in the article are indicative only and may differ from the actual ratio.

Leave a Comment

Your email address will not be published.